Controlled Release Delivery Conference

We announce the 15th Annual Controlled Release Delivery Conference in London on March 21st - 22nd 2018. As physicians continue to request drugs which have a reduced dosage requirement, higher action times and assist in simplifying treatment schedules for patients, the focus of the pharmaceutical industry is continually moving towards innovative controlled release delivery technologies, which improve drug transport to the target.

This year's event will bring together industry experts from pharmaceutical companies, regulatory agencies and biotechs to analyze and evaluate the latest advancements in Controlled Release Delivery, including the addressing formulation challenges of Abuse-Deterrent and oral lipid based Formulations, targeting controlled release delivery with Polymer Nanoparticles and how to overcome the additional challenges in controlled release delivery for pediatric medicine.

With the Oral Controlled Release Drug Delivery Technology Market expected to be worth $ 50,000 Mn in revenues by 2027, the event this year will have a particular focus on Oral Controlled Release Delivery technologies and will also examine the strategies, which pharmaceutical companies are using formulate new Controlled release drugs and scaling up from the batch process for commercial applications.

Benefits of Attending

• Understand the impact of the current EU Guideline on clinical evaluation of modified release drugs from a pharmaceutical perspective, with a talk from PLIVA
• Discover new technologies and innovations for the development of Controlled Release drugs including Lipid-composite microparticles, Molecular Envelope Technology (MET) nanoparticles and Abuse-Deterrent Formulations
• Focus on Successful Oral Technologies progressing in the clinic, with talks discussing lessons learned from clinical studies
• Learn about the advances and challenges in Paediatric controlled release formulations, including taste-masking and oral formulation challenges